💛 A quick favor, if you've got a second.
We're really happy that you chose to read one of our stories and sincerely hope you'll stick around to read more. We took our paywall down — for now — but that won't last forever, and when the gate goes back up, we'd love for you to already be on the inside.
It's free. So please enter your email here and don't forget to like and follow us on all of your favorite Social Media platforms!
Prominent memory experts from NYU Langone Medical Center recently engaged in a detailed discussion about Alzheimer’s disease during an interview with Bill Ritter, exploring the clinical indicators that signal disease onset and the therapeutic strategies now available to patients and families facing the condition.
The specialists addressed diagnostic protocols used to identify early signs of cognitive decline and detailed how healthcare providers distinguish Alzheimer’s from other forms of dementia. Their remarks highlighted advances in neuroimaging and biomarker testing that have improved the accuracy of diagnoses in recent years.
Treatment options ranging from pharmacological interventions to lifestyle modifications were examined during the conversation, with the experts emphasizing the importance of early intervention and ongoing care management for individuals diagnosed with the disease.
More Stories
New York Health Officials Sound Alarm Over Rising Measles Cases as School Year Approaches
CareCloud Breach Compromises 3.75 Million Patient Records, Among Largest Healthcare Data Thefts of 2026
Month-Long HEPA Use Linked to Faster Cognitive Processing in Middle-Aged Adults